Skip to main content
Dolores Sicheri, MD, Oncology, New York, NY

Dolores Anne Sicheri MD

Gynecologic Cancer


Physician

Join to View Full Profile
  • Retired2020 Whitegates drive. Thunder Bay OntarioNew York, NY 10016

  • Phone+1 807-983-3531

Dr. Sicheri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Dolores Sicheri is an oncologist in New York, NY. She received her medical degree from NYU School of Medicine and has been in practice 41 years. She specializes in gynecologic cancer.

Education & Training

  • New York University School of Medicine
    New York University School of MedicineClass of 1976
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsA.B., Biology-Biochemistry, 1972

Awards, Honors, & Recognition

  • Sigma XI 1985

Publications & Presentations

PubMed

Journal Articles

  • A Randomized Comparison of Melphalan with Prednisone or Dexamethasone as Induction Therapy and Dexamethasone or Observation as Maintenance Therapy in Multiple Myeloma  
    C Shustik, A Belch, S Robinson, S Rubin, S Dolan, M Kovacs, K Grewal, D Walde, R Barr, J Wilson, K Gill, L Vickars, L Rudinskas, D Sicheri, K Wilson, M Djurfeldt, L Sh..., Br J Haematol, 1/1/2007
  • A Phase 1 dose escalation study of a humanized monoclonal antibody to EGFR(hR3) in patients with locally advanced squamous cell cancer of the head and neck(SCCHN) tre...  
    A. Nabid, P Gamguly, V Venkatesan, K Schneider, D. Sicheri, J MacKinnon, S Laurie, E Winquist, International Journal of Radiation Oncology, Biology and Physics, 1/1/2002
  • Isolation and Characterization of HL 60, leukemia cells which exhibit a novel mechanism for resistance to Adriamycin  
    Marsh WB, Sicheri, DA, and Center, MS, Cancer Research, 1/1/1986

Books/Book Chapters

Abstracts/Posters

  • A phase I dose escalation study of a humanized monoclonal antibody to epidermal growth factor receptor in previously untreated head and neck cancer.
    E. Winquist, A. Nabid, D. Sicheri, P. Ganguly, V. Venkatesan, Schneider K, MacKinnon J., Laurie, S., ASCO, 1/1/2002
  • Experimental Meningeal Carcinomatosis in Canines
    Sicheri, D.A., AACR Proceedings; ACP Regional Meeting, Afton, OK, 1/1/1985

Lectures

  • Molecular Basis of Neoplasia 
    1/1/2016
  • Randomized Trial of Interferon Maintenance in Multiple Myeloma: A Study of the National Cancer Institute of Canada Clinical Trials Group 
    1/1/1993
  • Hemolytic Uremic Syndrome (HUS) with Chemotherapy 
    Afton, OK - 1/1/1987
  • Join now to see all

Other

  • Provincial guidelines for Cervical Cancer 
    Sicheri, D.A.
    1/1/2016
  • Provincial guidelines for Ovarian Cancer 
    Sicheri, D.A.
    1/1/2016
  • Oncology Syllabus 
    Sicheri, D.A.
    University of Oklahoma - 1/1/1983
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: